Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

The journal of pathology. Clinical research

Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menéndez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, García-Closas M.
PMID: 27499890
J Pathol Clin Res. 2014 Dec 04;1(1):18-32. doi: 10.1002/cjp2.3. eCollection 2015 Jan.

Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individual studies often lack the power required to assess these relationships, and large-scale analyses are limited by the need for high throughput, standardized scoring methods. To...

Cite
Howat WJ, Blows FM, Provenzano E, et al. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res. 2014;1(1):18-32doi: 10.1002/cjp2.3.
Howat, W. J., Blows, F. M., Provenzano, E., Brook, M. N., Morris, L., Gazinska, P., Johnson, N., McDuffus, L. A., Miller, J., Sawyer, E. J., Pinder, S., van Deurzen, C. H., Jones, L., Sironen, R., Visscher, D., Caldas, C., Daley, F., Coulson, P., Broeks, A., Sanders, J., Wesseling, J., Nevanlinna, H., Fagerholm, R., Blomqvist, C., Heikkilä, P., Ali, H. R., Dawson, S. J., Figueroa, J., Lissowska, J., Brinton, L., Mannermaa, A., Kataja, V., Kosma, V. M., Cox, A., Brock, I. W., Cross, S. S., Reed, M. W., Couch, F. J., Olson, J. E., Devillee, P., Mesker, W. E., Seyaneve, C. M., Hollestelle, A., Benitez, J., Perez, J. I., Menéndez, P., Bolla, M. K., Easton, D. F., Schmidt, M. K., Pharoah, P. D., Sherman, M. E., & García-Closas, M. (2015). Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. The journal of pathology. Clinical research, 1(1), 18-32. https://doi.org/10.1002/cjp2.3
Howat, William J, et al. "Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium." The journal of pathology. Clinical research vol. 1,1 (2015): 18-32. doi: https://doi.org/10.1002/cjp2.3
Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menéndez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, García-Closas M. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res. 2014 Dec 04;1(1):18-32. doi: 10.1002/cjp2.3. eCollection 2015 Jan. PMID: 27499890; PMCID: PMC4858117.
Copy Download .nbib Format: NLM
Impurity spin magnetization of thin Fe doped Au films.

Physical review letters

Seynaeve E, Temst K, Aliev FG, Van Haesendonck C, Gladilin VN, Fomin VM, Devreese JT.
PMID: 10978115
Phys Rev Lett. 2000 Sep 18;85(12):2593-6. doi: 10.1103/PhysRevLett.85.2593.

In order to probe the influence of the surface-induced anisotropy on the impurity spin magnetization, we measure the anomalous Hall effect in thin AuFe films at magnetic fields up to 15 T. The observed suppression of the anomalous Hall...

Cite
Seynaeve E, Temst K, Aliev FG, et al. Impurity spin magnetization of thin Fe doped Au films. Phys Rev Lett. 2000;85(12):2593-6doi: 10.1103/PhysRevLett.85.2593.
Seynaeve, E., Temst, K., Aliev, F. G., Van Haesendonck C, Gladilin, V. N., Fomin, V. M., & Devreese, J. T. (2000). Impurity spin magnetization of thin Fe doped Au films. Physical review letters, 85(12), 2593-6. https://doi.org/10.1103/PhysRevLett.85.2593
Seynaeve, et al. "Impurity spin magnetization of thin Fe doped Au films." Physical review letters vol. 85,12 (2000): 2593-6. doi: https://doi.org/10.1103/PhysRevLett.85.2593
Seynaeve E, Temst K, Aliev FG, Van Haesendonck C, Gladilin VN, Fomin VM, Devreese JT. Impurity spin magnetization of thin Fe doped Au films. Phys Rev Lett. 2000 Sep 18;85(12):2593-6. doi: 10.1103/PhysRevLett.85.2593. PMID: 10978115.
Copy Download .nbib Format: NLM
The Asp298Asn missense mutation in the porcine melanocortin-4 receptor ( MC4R) gene can be used to affect growth and carcass traits without an effect on meat quality.

Animal : an international journal of animal bioscience

Van den Maagdenberg K, Stinckens A, Claeys E, Seynaeve M, Clinquart A, Georges M, Buys N, De Smet S.
PMID: 22444853
Animal. 2007 Sep;1(8):1089-98. doi: 10.1017/S1751731107000456.

A promising tool to improve daily gain in pigs is the missense mutation (Asp298Asn) in the melanocortin-4 receptor (MC4R) gene, especially in the Belgian pig industry where the slow-growing Piétrain breed is very frequently used as the sire breed....

Cite
Van den Maagdenberg K, Stinckens A, Claeys E, et al. The Asp298Asn missense mutation in the porcine melanocortin-4 receptor ( MC4R) gene can be used to affect growth and carcass traits without an effect on meat quality. Animal. 2007;1(8):1089-98doi: 10.1017/S1751731107000456.
Van den Maagdenberg, K., Stinckens, A., Claeys, E., Seynaeve, M., Clinquart, A., Georges, M., Buys, N., & De Smet, S. (2007). The Asp298Asn missense mutation in the porcine melanocortin-4 receptor ( MC4R) gene can be used to affect growth and carcass traits without an effect on meat quality. Animal : an international journal of animal bioscience, 1(8), 1089-98. https://doi.org/10.1017/S1751731107000456
Van den Maagdenberg, K, et al. "The Asp298Asn missense mutation in the porcine melanocortin-4 receptor ( MC4R) gene can be used to affect growth and carcass traits without an effect on meat quality." Animal : an international journal of animal bioscience vol. 1,8 (2007): 1089-98. doi: https://doi.org/10.1017/S1751731107000456
Van den Maagdenberg K, Stinckens A, Claeys E, Seynaeve M, Clinquart A, Georges M, Buys N, De Smet S. The Asp298Asn missense mutation in the porcine melanocortin-4 receptor ( MC4R) gene can be used to affect growth and carcass traits without an effect on meat quality. Animal. 2007 Sep;1(8):1089-98. doi: 10.1017/S1751731107000456. PMID: 22444853.
Copy Download .nbib Format: NLM
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

Nature communications

Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Thienpont B, Neven P, Wildiers H, Broeks A, Van't Veer LJ, Rutgers EJT, Couch FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Hall P, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guénel P, Truong T, Menegaux F, Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Benitez J, Pilar Zamora M, Perez JIA, Menéndez P, Shu XO, Lu W, Gao YT, Cai Q, Cox A, Cross SS, Reed MWR, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip CH, Lee DSC, Wong TY, Hooning MJ, Martens JWM, Collée JM, van Deurzen CHM, Hopper JL, Southey MC, Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnæs GG, Borresen-Dale AL, Giles GG, Milne RL, McLean C, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Buhari SABS, Teo YY, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Simard J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Brauch H, Brüning T, Koto YD, Radice P, Peterlongo P, Bonanni B, Volorio S, Dörk T, Bogdanova NV, Helbig S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RAEM, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Hamann U, Torres D, Zheng W, Long J, Anton-Culver H, Neuhausen SL, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I, Carroll J, Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PDP, Chenevix-Trench G, French JD, Easton DF, Dunning AM.
PMID: 29633761
Nat Commun. 2018 Apr 10;9:16193. doi: 10.1038/ncomms16193.

This corrects the article DOI: 10.1038/ncomms5999.

Cite
Ghoussaini M, Edwards SL, Michailidou K, et al. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun. 2018;9:16193doi: 10.1038/ncomms16193.
Ghoussaini, M., Edwards, S. L., Michailidou, K., Nord, S., Cowper-Sal Lari, R., Desai, K., Kar, S., Hillman, K. M., Kaufmann, S., Glubb, D. M., Beesley, J., Dennis, J., Bolla, M. K., Wang, Q., Dicks, E., Guo, Q., Schmidt, M. K., Shah, M., Luben, R., Brown, J., Czene, K., Darabi, H., Eriksson, M., Klevebring, D., Bojesen, S. E., Nordestgaard, B. G., Nielsen, S. F., Flyger, H., Lambrechts, D., Thienpont, B., Neven, P., Wildiers, H., Broeks, A., Van't Veer, L. J., Rutgers, E. J. T., Couch, F. J., Olson, J. E., Hallberg, E., Vachon, C., Chang-Claude, J., Rudolph, A., Seibold, P., Flesch-Janys, D., Peto, J., Dos-Santos-Silva, I., Gibson, L., Nevanlinna, H., Muranen, T. A., Aittomäki, K., Blomqvist, C., Hall, P., Li, J., Liu, J., Humphreys, K., Kang, D., Choi, J. Y., Park, S. K., Noh, D. Y., Matsuo, K., Ito, H., Iwata, H., Yatabe, Y., Guénel, P., Truong, T., Menegaux, F., Sanchez, M., Burwinkel, B., Marme, F., Schneeweiss, A., Sohn, C., Wu, A. H., Tseng, C. C., Van Den Berg, D., Stram, D. O., Benitez, J., Pilar Zamora, M., Perez, J. I. A., Menéndez, P., Shu, X. O., Lu, W., Gao, Y. T., Cai, Q., Cox, A., Cross, S. S., Reed, M. W. R., Andrulis, I. L., Knight, J. A., Glendon, G., Tchatchou, S., Sawyer, E. J., Tomlinson, I., Kerin, M. J., Miller, N., Haiman, C. A., Henderson, B. E., Schumacher, F., Le Marchand, L., Lindblom, A., Margolin, S., Teo, S. H., Yip, C. H., Lee, D. S. C., Wong, T. Y., Hooning, M. J., Martens, J. W. M., Collée, J. M., van Deurzen, C. H. M., Hopper, J. L., Southey, M. C., Tsimiklis, H., Kapuscinski, M. K., Shen, C. Y., Wu, P. E., Yu, J. C., Chen, S. T., Alnæs, G. G., Borresen-Dale, A. L., Giles, G. G., Milne, R. L., McLean, C., Muir, K., Lophatananon, A., Stewart-Brown, S., Siriwanarangsan, P., Hartman, M., Miao, H., Buhari, S. A. B. S., Teo, Y. Y., Fasching, P. A., Haeberle, L., Ekici, A. B., Beckmann, M. W., Brenner, H., Dieffenbach, A. K., Arndt, V., Stegmaier, C., Swerdlow, A., Ashworth, A., Orr, N., Schoemaker, M. J., García-Closas, M., Figueroa, J., Chanock, S. J., Lissowska, J., Simard, J., Goldberg, M. S., Labrèche, F., Dumont, M., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Brauch, H., Brüning, T., Koto, Y. D., Radice, P., Peterlongo, P., Bonanni, B., Volorio, S., Dörk, T., Bogdanova, N. V., Helbig, S., Mannermaa, A., Kataja, V., Kosma, V. M., Hartikainen, J. M., Devilee, P., Tollenaar, R. A. E. M., Seynaeve, C., Van Asperen, C. J., Jakubowska, A., Lubinski, J., Jaworska-Bieniek, K., Durda, K., Slager, S., Toland, A. E., Ambrosone, C. B., Yannoukakos, D., Sangrajrang, S., Gaborieau, V., Brennan, P., McKay, J., Hamann, U., Torres, D., Zheng, W., Long, J., Anton-Culver, H., Neuhausen, S. L., Luccarini, C., Baynes, C., Ahmed, S., Maranian, M., Healey, C. S., González-Neira, A., Pita, G., Rosario Alonso, M., Álvarez, N., Herrero, D., Tessier, D. C., Vincent, D., Bacot, F., de Santiago, I., Carroll, J., Caldas, C., Brown, M. A., Lupien, M., Kristensen, V. N., Pharoah, P. D. P., Chenevix-Trench, G., French, J. D., Easton, D. F., & Dunning, A. M. (2018). Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature communications, 916193. https://doi.org/10.1038/ncomms16193
Ghoussaini, Maya, et al. "Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation." Nature communications vol. 9 (2018): 16193. doi: https://doi.org/10.1038/ncomms16193
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Thienpont B, Neven P, Wildiers H, Broeks A, Van't Veer LJ, Rutgers EJT, Couch FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Hall P, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guénel P, Truong T, Menegaux F, Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Benitez J, Pilar Zamora M, Perez JIA, Menéndez P, Shu XO, Lu W, Gao YT, Cai Q, Cox A, Cross SS, Reed MWR, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip CH, Lee DSC, Wong TY, Hooning MJ, Martens JWM, Collée JM, van Deurzen CHM, Hopper JL, Southey MC, Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnæs GG, Borresen-Dale AL, Giles GG, Milne RL, McLean C, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Buhari SABS, Teo YY, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Simard J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Brauch H, Brüning T, Koto YD, Radice P, Peterlongo P, Bonanni B, Volorio S, Dörk T, Bogdanova NV, Helbig S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RAEM, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Hamann U, Torres D, Zheng W, Long J, Anton-Culver H, Neuhausen SL, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I, Carroll J, Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PDP, Chenevix-Trench G, French JD, Easton DF, Dunning AM. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun. 2018 Apr 10;9:16193. doi: 10.1038/ncomms16193. PMID: 29633761; PMCID: PMC5898457.
Copy Download .nbib Format: NLM
Publisher Correction: Using high-amplitude and focused transcranial alternating current stimulation to entrain physiological tremor.

Scientific reports

Khatoun A, Breukers J, Op de Beeck S, Nica IG, Aerts JM, Seynaeve L, Haeck T, Asamoah B, Mc Laughlin M.
PMID: 29795166
Sci Rep. 2018 May 23;8(1):8221. doi: 10.1038/s41598-018-26013-3.

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Cite
Khatoun A, Breukers J, Op de Beeck S, et al. Publisher Correction: Using high-amplitude and focused transcranial alternating current stimulation to entrain physiological tremor. Sci Rep. 2018;8(1):8221doi: 10.1038/s41598-018-26013-3.
Khatoun, A., Breukers, J., Op de Beeck, S., Nica, I. G., Aerts, J. M., Seynaeve, L., Haeck, T., Asamoah, B., & Mc Laughlin, M. (2018). Publisher Correction: Using high-amplitude and focused transcranial alternating current stimulation to entrain physiological tremor. Scientific reports, 8(1), 8221. https://doi.org/10.1038/s41598-018-26013-3
Khatoun, Ahmad, et al. "Publisher Correction: Using high-amplitude and focused transcranial alternating current stimulation to entrain physiological tremor." Scientific reports vol. 8,1 (2018): 8221. doi: https://doi.org/10.1038/s41598-018-26013-3
Khatoun A, Breukers J, Op de Beeck S, Nica IG, Aerts JM, Seynaeve L, Haeck T, Asamoah B, Mc Laughlin M. Publisher Correction: Using high-amplitude and focused transcranial alternating current stimulation to entrain physiological tremor. Sci Rep. 2018 May 23;8(1):8221. doi: 10.1038/s41598-018-26013-3. PMID: 29795166; PMCID: PMC5964328.
Copy Download .nbib Format: NLM
Imaging the elastic properties of coiled carbon nanotubes with atomic force microscopy.

Physical review letters

Volodin A, Ahlskog M, Seynaeve E, Van Haesendonck C, Fonseca A, Nagy JB.
PMID: 11019085
Phys Rev Lett. 2000 Apr 10;84(15):3342-5. doi: 10.1103/PhysRevLett.84.3342.

Coiled carbon nanotubes were produced catalytically by thermal decomposition of hydrocarbon gas. After deposition on a silicon substrate, the three-dimensional structure of the helix-shaped multiwalled nanotubes can be visualized with atomic force microscopy. Helical structures of both chiralities are...

Cite
Volodin A, Ahlskog M, Seynaeve E, et al. Imaging the elastic properties of coiled carbon nanotubes with atomic force microscopy. Phys Rev Lett. 2000;84(15):3342-5doi: 10.1103/PhysRevLett.84.3342.
Volodin, A., Ahlskog, M., Seynaeve, E., Van Haesendonck C, Fonseca, A., & Nagy, J. B. (2000). Imaging the elastic properties of coiled carbon nanotubes with atomic force microscopy. Physical review letters, 84(15), 3342-5. https://doi.org/10.1103/PhysRevLett.84.3342
Volodin, et al. "Imaging the elastic properties of coiled carbon nanotubes with atomic force microscopy." Physical review letters vol. 84,15 (2000): 3342-5. doi: https://doi.org/10.1103/PhysRevLett.84.3342
Volodin A, Ahlskog M, Seynaeve E, Van Haesendonck C, Fonseca A, Nagy JB. Imaging the elastic properties of coiled carbon nanotubes with atomic force microscopy. Phys Rev Lett. 2000 Apr 10;84(15):3342-5. doi: 10.1103/PhysRevLett.84.3342. PMID: 11019085.
Copy Download .nbib Format: NLM
Electrocorticography of Spatial Shifting and Attentional Selection in Human Superior Parietal Cortex.

Frontiers in human neuroscience

Schrooten M, Ghumare EG, Seynaeve L, Theys T, Dupont P, Van Paesschen W, Vandenberghe R.
PMID: 28553217
Front Hum Neurosci. 2017 May 11;11:240. doi: 10.3389/fnhum.2017.00240. eCollection 2017.

Spatial-attentional reorienting and selection between competing stimuli are two distinct attentional processes of clinical and fundamental relevance. In the past, reorienting has been mainly associated with inferior parietal cortex. In a patient with a subdural grid covering the upper...

Cite
Schrooten M, Ghumare EG, Seynaeve L, et al. Electrocorticography of Spatial Shifting and Attentional Selection in Human Superior Parietal Cortex. Front Hum Neurosci. 2017;11:240doi: 10.3389/fnhum.2017.00240.
Schrooten, M., Ghumare, E. G., Seynaeve, L., Theys, T., Dupont, P., Van Paesschen, W., & Vandenberghe, R. (2017). Electrocorticography of Spatial Shifting and Attentional Selection in Human Superior Parietal Cortex. Frontiers in human neuroscience, 11240. https://doi.org/10.3389/fnhum.2017.00240
Schrooten, Maarten, et al. "Electrocorticography of Spatial Shifting and Attentional Selection in Human Superior Parietal Cortex." Frontiers in human neuroscience vol. 11 (2017): 240. doi: https://doi.org/10.3389/fnhum.2017.00240
Schrooten M, Ghumare EG, Seynaeve L, Theys T, Dupont P, Van Paesschen W, Vandenberghe R. Electrocorticography of Spatial Shifting and Attentional Selection in Human Superior Parietal Cortex. Front Hum Neurosci. 2017 May 11;11:240. doi: 10.3389/fnhum.2017.00240. eCollection 2017. PMID: 28553217; PMCID: PMC5425472.
Copy Download .nbib Format: NLM
Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis.

Frontiers in neurology

Wiels WA, Du Four S, Seynaeve L, Flamez A, Tousseyn T, Thal D, D'Haeseleer M.
PMID: 29755395
Front Neurol. 2018 Apr 10;9:242. doi: 10.3389/fneur.2018.00242. eCollection 2018.

OBJECTIVES: The objective of this study is to explore the clinical, radiological, and pathological manifestations of a rare subtype of prion disease and their implication for differential diagnosis in case of an early onset neuropsychiatric deterioration.METHODS: We discuss a...

Cite
Wiels WA, Du Four S, Seynaeve L, et al. Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis. Front Neurol. 2018;9:242doi: 10.3389/fneur.2018.00242.
Wiels, W. A., Du Four, S., Seynaeve, L., Flamez, A., Tousseyn, T., Thal, D., & D'Haeseleer, M. (2018). Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis. Frontiers in neurology, 9242. https://doi.org/10.3389/fneur.2018.00242
Wiels, Wietse A, et al. "Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis." Frontiers in neurology vol. 9 (2018): 242. doi: https://doi.org/10.3389/fneur.2018.00242
Wiels WA, Du Four S, Seynaeve L, Flamez A, Tousseyn T, Thal D, D'Haeseleer M. Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis. Front Neurol. 2018 Apr 10;9:242. doi: 10.3389/fneur.2018.00242. eCollection 2018. PMID: 29755395; PMCID: PMC5932381.
Copy Download .nbib Format: NLM
[No title available]

Oncotarget

Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, Kremeyer B, Luo L, von Holst S, Kontham V, Thutkawkorapin J, Margolin S, Du Q, Lundin J, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Beckmann MW, Blomqvist C, Blot W, Boeckx B, Bojesen SE, Bonanni B, Brand JS, Brauch H, Brenner H, Broeks A, Brüning T, Burwinkel B, Cai Q, Chang-Claude J, Couch FJ, Cox A, Cross SS, Deming-Halverson SL, Devilee P, Dos-Santos-Silva I, Dörk T, Eriksson M, Fasching PA, Figueroa J, Flesch-Janys D, Flyger H, Gabrielson M, García-Closas M, Giles GG, González-Neira A, Guénel P, Guo Q, Gündert M, Haiman CA, Hallberg E, Hamann U, Harrington P, Hooning MJ, Hopper JL, Huang G, Jakubowska A, Jones ME, Kerin MJ, Kosma VM, Kristensen VN, Lambrechts D, Le Marchand L, Lubinski J, Mannermaa A, Martens JWM, Meindl A, Milne RL, Mulligan AM, Neuhausen SL, Nevanlinna H, Peto J, Pylkäs K, Radice P, Rhenius V, Sawyer EJ, Schmidt MK, Schmutzler RK, Seynaeve C, Shah M, Simard J, Southey MC, Swerdlow AJ, Truong T, Wendt C, Winqvist R, Zheng W, Benitez J, Dunning AM, Pharoah PDP, Easton DF, Czene K, Hall P, Lindblom A.
PMID: 29262523
Oncotarget. 2017 Oct 12;8(61):102769-102782. doi: 10.18632/oncotarget.21800. eCollection 2017 Nov 28.

Most non-

Cite
Jiao X, Aravidis C, Marikkannu R, et al. . Oncotarget. 2017;8(61):102769-102782doi: 10.18632/oncotarget.21800.
Jiao, X., Aravidis, C., Marikkannu, R., Rantala, J., Picelli, S., Adamovic, T., Liu, T., Maguire, P., Kremeyer, B., Luo, L., von Holst, S., Kontham, V., Thutkawkorapin, J., Margolin, S., Du, Q., Lundin, J., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Lush, M., Ambrosone, C. B., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Arndt, V., Beckmann, M. W., Blomqvist, C., Blot, W., Boeckx, B., Bojesen, S. E., Bonanni, B., Brand, J. S., Brauch, H., Brenner, H., Broeks, A., Brüning, T., Burwinkel, B., Cai, Q., Chang-Claude, J., Couch, F. J., Cox, A., Cross, S. S., Deming-Halverson, S. L., Devilee, P., Dos-Santos-Silva, I., Dörk, T., Eriksson, M., Fasching, P. A., Figueroa, J., Flesch-Janys, D., Flyger, H., Gabrielson, M., García-Closas, M., Giles, G. G., González-Neira, A., Guénel, P., Guo, Q., Gündert, M., Haiman, C. A., Hallberg, E., Hamann, U., Harrington, P., Hooning, M. J., Hopper, J. L., Huang, G., Jakubowska, A., Jones, M. E., Kerin, M. J., Kosma, V. M., Kristensen, V. N., Lambrechts, D., Le Marchand, L., Lubinski, J., Mannermaa, A., Martens, J. W. M., Meindl, A., Milne, R. L., Mulligan, A. M., Neuhausen, S. L., Nevanlinna, H., Peto, J., Pylkäs, K., Radice, P., Rhenius, V., Sawyer, E. J., Schmidt, M. K., Schmutzler, R. K., Seynaeve, C., Shah, M., Simard, J., Southey, M. C., Swerdlow, A. J., Truong, T., Wendt, C., Winqvist, R., Zheng, W., Benitez, J., Dunning, A. M., Pharoah, P. D. P., Easton, D. F., Czene, K., Hall, P., & Lindblom, A. (2017). . Oncotarget, 8(61), 102769-102782. https://doi.org/10.18632/oncotarget.21800
Jiao, Xiang, et al. "." Oncotarget vol. 8,61 (2017): 102769-102782. doi: https://doi.org/10.18632/oncotarget.21800
Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, Kremeyer B, Luo L, von Holst S, Kontham V, Thutkawkorapin J, Margolin S, Du Q, Lundin J, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Beckmann MW, Blomqvist C, Blot W, Boeckx B, Bojesen SE, Bonanni B, Brand JS, Brauch H, Brenner H, Broeks A, Brüning T, Burwinkel B, Cai Q, Chang-Claude J, Couch FJ, Cox A, Cross SS, Deming-Halverson SL, Devilee P, Dos-Santos-Silva I, Dörk T, Eriksson M, Fasching PA, Figueroa J, Flesch-Janys D, Flyger H, Gabrielson M, García-Closas M, Giles GG, González-Neira A, Guénel P, Guo Q, Gündert M, Haiman CA, Hallberg E, Hamann U, Harrington P, Hooning MJ, Hopper JL, Huang G, Jakubowska A, Jones ME, Kerin MJ, Kosma VM, Kristensen VN, Lambrechts D, Le Marchand L, Lubinski J, Mannermaa A, Martens JWM, Meindl A, Milne RL, Mulligan AM, Neuhausen SL, Nevanlinna H, Peto J, Pylkäs K, Radice P, Rhenius V, Sawyer EJ, Schmidt MK, Schmutzler RK, Seynaeve C, Shah M, Simard J, Southey MC, Swerdlow AJ, Truong T, Wendt C, Winqvist R, Zheng W, Benitez J, Dunning AM, Pharoah PDP, Easton DF, Czene K, Hall P, Lindblom A. . Oncotarget. 2017 Oct 12;8(61):102769-102782. doi: 10.18632/oncotarget.21800. eCollection 2017 Nov 28. PMID: 29262523; PMCID: PMC5732689.
Copy Download .nbib Format: NLM
Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy.

Hereditary cancer in clinical practice

Tan MB, Bleiker EM, Menke-Pluymers MB, Van Gool AR, van Dooren S, Van Geel BN, Tilanus-Linthorst MM, Bartels KC, Klijn JG, Brekelmans CT, Seynaeve C.
PMID: 19338651
Hered Cancer Clin Pract. 2009 Mar 31;7(1):6. doi: 10.1186/1897-4287-7-6.

BACKGROUND: Women at increased (genetic) risk of breast cancer have to weigh the personal pros and cons of prophylactic mastectomy (PM) as an option to reduce their cancer risk. So far, no routine referral to a psychologist has been...

Cite
Tan MB, Bleiker EM, Menke-Pluymers MB, et al. Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy. Hered Cancer Clin Pract. 2009;7(1):6doi: 10.1186/1897-4287-7-6.
Tan, M. B., Bleiker, E. M., Menke-Pluymers, M. B., Van Gool, A. R., van Dooren, S., Van Geel, B. N., Tilanus-Linthorst, M. M., Bartels, K. C., Klijn, J. G., Brekelmans, C. T., & Seynaeve, C. (2009). Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy. Hereditary cancer in clinical practice, 7(1), 6. https://doi.org/10.1186/1897-4287-7-6
Tan, Murly B M, et al. "Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy." Hereditary cancer in clinical practice vol. 7,1 (2009): 6. doi: https://doi.org/10.1186/1897-4287-7-6
Tan MB, Bleiker EM, Menke-Pluymers MB, Van Gool AR, van Dooren S, Van Geel BN, Tilanus-Linthorst MM, Bartels KC, Klijn JG, Brekelmans CT, Seynaeve C. Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy. Hered Cancer Clin Pract. 2009 Mar 31;7(1):6. doi: 10.1186/1897-4287-7-6. PMID: 19338651; PMCID: PMC2667399.
Copy Download .nbib Format: NLM
Body condition and habitat use by Hermann's tortoises in burnt and intact habitats.

Conservation physiology

Lecq S, Ballouard JM, Caron S, Livoreil B, Seynaeve V, Matthieu LA, Bonnet X.
PMID: 27293640
Conserv Physiol. 2014 Jun 12;2(1):cou019. doi: 10.1093/conphys/cou019. eCollection 2014.

UNLABELLED: In Mediterranean regions, fires threaten terrestrial tortoises. Nevertheless, varying proportions of adults survive fire; these surviving individuals can play a central role for population recovery. The regions devastated by fire often include important habitat of Hermann's tortoises (Testudo...

Cite
Lecq S, Ballouard JM, Caron S, et al. Body condition and habitat use by Hermann's tortoises in burnt and intact habitats. Conserv Physiol. 2014;2(1):cou019doi: 10.1093/conphys/cou019.
Lecq, S., Ballouard, J. M., Caron, S., Livoreil, B., Seynaeve, V., Matthieu, L. A., & Bonnet, X. (2014). Body condition and habitat use by Hermann's tortoises in burnt and intact habitats. Conservation physiology, 2(1), cou019. https://doi.org/10.1093/conphys/cou019
Lecq, S, et al. "Body condition and habitat use by Hermann's tortoises in burnt and intact habitats." Conservation physiology vol. 2,1 (2014): cou019. doi: https://doi.org/10.1093/conphys/cou019
Lecq S, Ballouard JM, Caron S, Livoreil B, Seynaeve V, Matthieu LA, Bonnet X. Body condition and habitat use by Hermann's tortoises in burnt and intact habitats. Conserv Physiol. 2014 Jun 12;2(1):cou019. doi: 10.1093/conphys/cou019. eCollection 2014. PMID: 27293640; PMCID: PMC4732473.
Copy Download .nbib Format: NLM
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial.

Journal for immunotherapy of cancer

Duerinck J, Schwarze JK, Awada G, Tijtgat J, Vaeyens F, Bertels C, Geens W, Klein S, Seynaeve L, Cras L, D'Haene N, Michotte A, Caljon B, Salmon I, Bruneau M, Kockx M, Van Dooren S, Vanbinst AM, Everaert H, Forsyth R, Neyns B.
PMID: 34168003
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2020-002296.

BACKGROUND: Patients with recurrent glioblastoma (rGB) have a poor prognosis with a median overall survival (OS) of 30-39 weeks in prospective clinical trials. Intravenous administration of programmed cell death protein 1 and cytotoxic T-lymphocyte-associated antigen 4 inhibitors has low...

Cite
Duerinck J, Schwarze JK, Awada G, et al. Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial. J Immunother Cancer. 2021;9(6)doi: 10.1136/jitc-2020-002296.
Duerinck, J., Schwarze, J. K., Awada, G., Tijtgat, J., Vaeyens, F., Bertels, C., Geens, W., Klein, S., Seynaeve, L., Cras, L., D'Haene, N., Michotte, A., Caljon, B., Salmon, I., Bruneau, M., Kockx, M., Van Dooren, S., Vanbinst, A. M., Everaert, H., Forsyth, R., & Neyns, B. (2021). Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial. Journal for immunotherapy of cancer, 9(6), . https://doi.org/10.1136/jitc-2020-002296
Duerinck, Johnny, et al. "Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial." Journal for immunotherapy of cancer vol. 9,6 (2021). doi: https://doi.org/10.1136/jitc-2020-002296
Duerinck J, Schwarze JK, Awada G, Tijtgat J, Vaeyens F, Bertels C, Geens W, Klein S, Seynaeve L, Cras L, D'Haene N, Michotte A, Caljon B, Salmon I, Bruneau M, Kockx M, Van Dooren S, Vanbinst AM, Everaert H, Forsyth R, Neyns B. Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial. J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2020-002296. PMID: 34168003; PMCID: PMC8231061.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries